Metaclipse Therapeutics metaclipse.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1133)

Metaclipse Therapeutics is developing a personalized cancer immunotherapy using tumor membrane vesicles prepared from the patient's own tumor and combined with immune-stimulatory molecules.

Metaclipse Therapeutics is developing a personalized cancer immunotherapy using tumor membrane vesicles prepared from the patient's own tumor and combined with immune-stimulatory molecules.

Company (Alive / Active)

Phone: 404-380-1342

Fax:

3175 Presidential Drive

Atlanta, 30340
Georgia, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Metaclipse Therapeutics $0M Mar 2, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Metaclipse Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods of treating with tumor membrane vesicle-based immunotherapy and predicting therapeutic response thereto Nov 08, 2017 Application